Clinical value of biochemical immunoassay in diagnosis of renal diseases
生化免疫检验在肾脏疾病诊断中的临床应用价值

摘要

目的 探究在肾脏疾病中应用生化免疫检验的诊断价值。方法 文章研究人员选取时间2021年5月到2022年7月，入选患者共120人，均为我院肾脏内科收诊患者，利用统计学方法进行分组，即观察组（生化免疫检验）、对照组（生化检验），每组60人，比对组间肾脏疾病检出率、与病理结果对比的符合率以及患者对诊断方式的满意度。结果 观察组诊断方式最终检出率更高，P值＜0.05；观察组诊断结果与后期病理学结果相比，符合率更高，P值小于0.05。结论 在临床肾脏疾病的检测中，使用生化免疫检验疾病检出率和准确率更高，可以为后续诊疗提供相对可靠的资料依据。

Abstract

Objective To explore the diagnostic value of biochemical immunoassay in renal diseases.
Methods the researchers selected 120 patients from May 2021 to July 2022, all of whom were admitted to the nephrology department of our hospital. They were divided into observation group (biochemical immune test) and control group (biochemical test) with 60 people in each group by statistical methods. The detection rate of renal diseases between the comparison groups, the coincidence rate with pathological results and the satisfaction of patients with the diagnosis method were compared.
Results the final detection rate of the observation group was higher (P < 0.05); Compared with the later pathological results, the coincidence rate of the diagnosis results in the observation group was higher (P < 0.05); Patients in the observation group were significantly more satisfied with the detection mode than those in the other group (P < 0.05).
Conclusion   in the detection of clinical renal diseases, the detection rate and accuracy of biochemical immunoassay are higher, which can provide relatively reliable data for follow-up diagnosis and treatment.